NCI Chemical Biology Consortium Symposium: Catch the Wave – Innovations in Cancer Therapeutics (Agenda)

Agenda

The following times listed are all indicated in Pacific Standard Time (PST).

Wednesday | January 31, 2024
8:30 am Registration and Coffee
9:00 am Welcome Remarks
(James Doroshow, Michael Jackson)
9:10 am James H. Doroshow M.D.
Rare Cancer Models for Therapeutic Development
Director of the Division of Cancer Treatment and Diagnosis, National Cancer Institute
9:40 am Ben Cravatt, Ph.D.
Activity-based proteomics - cancer target and ligand discovery on a global scale
Professor, Chemistry, Scripps Research
10:10 am Anthony Pinkerton, Ph.D.
Synthetic lethality in a plastic genome: Overcoming extrachromosomal DNA and oncogene amplification to address unmet needs in cancer
Senior VP, Chemistry, Boundless Bio
10:40 am Coffee Break
11:10 am Fleur Ferguson, Ph.D.
Interrogating the druggable proteome with proximity pharmacology
Assistant Professor, Skagg School Pharmacy and Pharmaceutical sciences, UCSD
11:40 am Ray Deshaies, Ph.D.
New frontiers in small molecule drug discovery
Snr VP Global Research, Amgen
12:10 pm Lunch
1:10 pm Tom Miller, Ph.D.
AI-driven discovery of 1000-fold selective and CNS-penetrant Her2 inhibitor
CEO Iambic Therapeutics
1:40pm Sanju Sinha, Ph.D.
DeepTarget: Predicting in-depth mechanism of actions for small molecule inhibitors
Assistant Professor, SBP Cancer Center
2:10 pm Stephen Worland, Ph.D.
STRIs: A New Class of Cancer Therapeutics that Regulate Gene Expression at the Step of RNA Translation
CEO, eFFECTOR Therapeutics
2:40pm Coffee Break
3:10 pm Susanne Heynen-Genel, Ph.D. (Director, High Content Imaging Platforms, SBP) High-throughput phenotypic screening - a path to novel cancer therapeutics
3:40 pm Matt Hall, Ph.D., Director, Early Translational Branch, NCATS, and
Jennifer Cox, Ph.D., Executive Director, Biology, Chinook
From cancer to rare disease: The pre-clinical development of lactate dehydrogenase inhibitors
4:10 pm Reuben Shaw, Ph.D.
Targeting autophagy to treat cancer
Professor, Molecular and Cell Biology Laboratory
Director, Salk NCI-Designated Cancer Center
4:40 pm Networking and Poster
6:00 pm Adjourn Meeting